Results for tag: "Myofascial Pain Syndrome Drug"

Myofascial Pain Syndrome (MPS) is a chronic pain disorder that affects the muscles and fascia, the connective tissue that surrounds the muscles. It is caused by the buildup of tension in the muscles, which can lead to pain and tenderness. Treatment for MPS typically involves medications, physical therapy, and lifestyle changes. Central Nervous System (CNS) drugs are used to treat MPS, as they can help reduce pain and inflammation. Common CNS drugs used to treat MPS include non-steroidal anti-inflammatory drugs (NSAIDs), muscle relaxants, and anticonvulsants. These drugs can help reduce pain and improve mobility, allowing patients to return to their normal activities. The Myofascial Pain Syndrome Drug market is a growing market, as more people are being diagnosed with MPS and seeking treatment. Companies in this market include Pfizer, Merck, Novartis, and GlaxoSmithKline. These companies are developing new drugs and treatments to help improve the quality of life for those suffering from MPS. Show Less Read more